Methyl 4-amino-1-(4-chlorobenzyl)piperidine-4-carboxylate dihydrochloride

Catalog No. :
ACRBWJ506
CAS No. :
1210494-26-0
Molecular Formula :
C14H21Cl3N2O2
Molecular Weight :
355.69

IUPAC Name:methyl 4-amino-1-(4-chlorobenzyl)piperidine-4-carboxylate dihydrochloride

Methyl 4-amino-1-(4-chlorobenzyl)piperidine-4-carboxylate dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg96%$118.00Login to see priceInquiryInquiry
1g96%$263.00Login to see priceInquiryInquiry
5g96%$740.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-amino-1-(4-chlorobenzyl)piperidine-4-carboxylate dihydrochloride
IUPAC Namemethyl 4-amino-1-(4-chlorobenzyl)piperidine-4-carboxylate dihydrochloride
MDL No.MFCD08543515
Molecular FormulaC14H21Cl3N2O2
Molecular Weight355.69
SMILESO=C(C1(N)CCN(CC2=CC=C(Cl)C=C2)CC1)OC.[H]Cl.[H]Cl
InChI KeyLTUTUBUEURQDLJ-UHFFFAOYSA-N
Synonym1210494-26-0 | Methyl 4-amino-1-(4-chlorobenzyl)piperidine-4-carboxylate dihydrochloride | 4-amino-1-(4-chloro-benzyl)-piperidine-4-carboxylic acid methyl ester dihydrochloride | methyl 4-amino-1-[(4-chlorophenyl)methyl]piperidine-4-carboxylate;dihydrochloride |
CAS No.1210494-26-0
PubChem CID45789709

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRBWJ506 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRBWJ506 route product structure diagram
    ACRBWJ5061210494-26-0
Inquiry

2. ACRBWJ506 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRBWJ506 route product structure diagram
    ACRBWJ5061210494-26-0
Inquiry

Comments (0)